The American Association for Cancer Research will release the AACR Cancer Progress Report 2024 at 11:30 a.m. ET on Wednesday, September 18, 2024, at a congressional briefing online or in person.
Register NowCancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreDisparities in Cancer Screening: Racial and ethnic minority populations and medically underserved communities experience substantial disparities in receiving the recommended cancer screenings.
Read the ReportMore than 83,000 people in the United States are expected to be diagnosed with bladder cancer this year. Learn more about screening and treatment for this type of cancer.
Learn MoreThyroid Cancer: Playing ‘Molecular Chess’ Against a Grandmaster
Read MoreMaking Treatment Decisions: Abigail Johnston shares how she has approached decisions about her cancer care since she was diagnosed with metastatic breast cancer in 2017.
Read Practical KnowledgeWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through September 3.
The AACR Cancer Disparities Progress Report 2024 outlines the complex interplay of factors that drive and perpetuate cancer health disparities and calls for a collaborative approach to achieve health equity.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. Winn, chair of the AACR Cancer Disparities Progress Report 2024 steering committee, discusses the many factors that drive and perpetuate cancer health disparities.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2020
Learn Moretherapeutics were approved for new or expanded uses by the FDA from Aug. 1, 2022, to July 31, 2023
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More